Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Jun 24;168(13):1644; author reply 1645-6.

Osteoporosis guidelines

Edmund R Yendt
Comment

Osteoporosis guidelines

Edmund R Yendt. CMAJ. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(10 Suppl):S1-34. - PMC - PubMed
    1. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen R, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999;282:637-45. - PubMed
    1. Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Adachi J, et al. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 2002;23:524-8. - PubMed
    1. Evista® (raloxifene) product monograph. Toronto: Eli Lilly Canada Inc.; 2000 Jul 26.
    1. Johnston CC Jr, Bjarnason NH, Cohen FS, Shah A, Lindsay R, Mitlak BH, et al. Long-term effects of raloxifene on bone mineral density, bone turnover and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med 2000;160:3444-50. - PubMed

MeSH terms

Substances